Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Скринер
Новости
О нас

Home

/

GMED

G

Globus Medical, Inc. (GMED)

NYQ – Цена в реальном времени. Валюта: USD

76.13

-0.55 (-0.72%)

При закрытии: May 12, 2026, 4:00 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY

3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY

These highly ranked medical stocks have been capitalizing on their sales expansion, and their defensive or secular growth profiles could become even more attractive if an economic downturn emerges.

3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED)

Globus Medical (GMED) could produce exceptional returns because of its solid growth attributes.

Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED)

Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED)

The heavy selling pressure might have exhausted for Globus Medical (GMED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Globus Medical Q1 Earnings Call Highlights

Globus Medical Q1 Earnings Call Highlights

Globus Medical NYSE: GMED reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U.S. spine, margin expansion and contributions from its Nevro acquisition.

GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised

GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised

Globus Medical beats Q1 EPS estimates by 22% as revenues rise 27% to $759.9M; margins widen and 2026 EPS outlook up, lifting shares 5.8%.

Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates

Globus Medical (GMED) Tops Q1 Earnings and Revenue Estimates

Globus Medical (GMED) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.68 per share a year ago.

Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript

Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript

Globus Medical, Inc. (GMED) Q1 2026 Earnings Call Transcript

Видео

No Data

There is no data to display

Пресс-релизы

Globus Medical Reports First Quarter 2026 Results

Globus Medical Reports First Quarter 2026 Results

AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026.

Globus Medical Announces Board Departure

23.03.2026

Globus Medical Announces Board Departure

AUDUBON, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that John A. DeFord, PhD, a Director of Globus Medical Inc., notified the company of his decision to step down from the Board of Directors effective immediately and will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026.

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025.

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

AUDUBON, Pa., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2025. The company anticipates fourth quarter 2025 sales of approximately $823.2 million, an increase of 25.2 percent over the fourth quarter 2024 on an as-reported basis. Full year 2025 sales are expected to be approximately $2.936 billion, an increase of 16.5 percent over the prior year on an as-reported basis.